FDA Approves Datroway for Pretreated Advanced Breast Cancer
MedPage Today) — The FDA approved datopotamab deruxtecan (Datroway) for adults with unresectable or metastatic, hormone receptor (HR)-positive/HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable…
MedPage Today) — The FDA approved datopotamab deruxtecan (Datroway) for adults with unresectable or metastatic, hormone receptor (HR)-positive/HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable…
Read More
About Author
